Literature DB >> 8645837

Opportunistic candidiasis: an epidemic of the 1980s.

S P Fisher-Hoch1, L Hutwagner.   

Abstract

Hospital discharge data from 1980 to 1989 from the National Center for Health Statistics, National Hospital Discharge Survey (NHDH), and two commercially generated hospital discharge data sources (PAS and McAuto) were analyzed to document nationally the increased rate of opportunistic candidal infections among hospitalized patients in the 1980s and to identify the major risk factors. National projections were made by year. Age-, sex-, race-, and disease-specific denominators were generated from NHDS data. ICD-9-CM codes derived from discharge diagnoses were used to identify patients with oropharyngeal candidiasis, disseminated candidiasis, human immunodeficiency virus (HIV) infection/AIDS, or malignancies and transplants. Between 1980 and 1989, rates of oropharyngeal candidiasis increased 4.7 times (from 0.34 to 1.6 cases per 1,000 admissions per year), and the number of deaths among patients with oropharyngeal candidiasis increased fivefold. Although the highest rates were among pediatric patients (3 cases per 1,000 pediatric admissions), the greatest rate increases were among 15- to 44-year-old patients (13-fold) and males (fivefold). Between 1983 and 1989, the rates of oropharyngeal candidiasis among patients with HIV infections/AIDS rose more than 22 times (from 0.02 to 0.45 case per 1,000 admissions; NHDS data). Over the whole decade, the rates of disseminated candidiasis increased 11 times (from 0.013 to 0.15 case per 1,000 admissions). Between 1985 and 1989, the rate of this complication among patients with HIV infection/AIDS increased 10-fold, compared with only a twofold rate increase among patients with malignancies or transplants. The rate of debilitating and life-threatening candidiasis among hospitalized patients increased considerably over the 1980s. This rate increase was significant among patients with HIV infection/AIDS and patients undergoing transplantation or immunosuppressive therapy for malignancies.

Entities:  

Mesh:

Year:  1995        PMID: 8645837     DOI: 10.1093/clinids/21.4.897

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  27 in total

1.  CD8 T cells and E-cadherin in host responses against oropharyngeal candidiasis.

Authors:  K Quimby; E A Lilly; M Zacharek; K McNulty; J E Leigh; J E Vazquez; P L Fidel
Journal:  Oral Dis       Date:  2011-09-30       Impact factor: 3.511

2.  Purification and biochemical characterization of a 65-kilodalton mannoprotein (MP65), a main target of anti-Candida cell-mediated immune responses in humans.

Authors:  M J Gomez; A Torosantucci; S Arancia; B Maras; L Parisi; A Cassone
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Hybridoma passage in vitro may result in reduced ability of antimannan antibody to protect against disseminated candidiasis.

Authors:  Hong Xin; Jim E Cutler
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 4.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

5.  Clinical correlates of antifungal macrodilution susceptibility test results for non-AIDS patients with severe Candida infections treated with fluconazole.

Authors:  S C Lee; C P Fung; J S Huang; C J Tsai; K S Chen; H Y Chen; N Lee; L C See; W B Shieh
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

Review 6.  Azole resistance in Candida.

Authors:  D W Denning; G G Baily; S V Hood
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-04       Impact factor: 3.267

7.  Candida pseudorugosa sp. nov., a novel yeast species from sputum.

Authors:  Juan Li; Ying-Chun Xu; Feng-Yan Bai
Journal:  J Clin Microbiol       Date:  2006-10-04       Impact factor: 5.948

8.  Epidemiology of nosocomial fungal infections.

Authors:  S K Fridkin; W R Jarvis
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

9.  Synthesis of some novel hydrazono acyclic nucleoside analogues.

Authors:  Mohammad N Soltani Rad; Ali Khalafi-Nezhad; Somayeh Behrouz
Journal:  Beilstein J Org Chem       Date:  2010-05-17       Impact factor: 2.883

10.  Clinical factors associated with fluconazole resistance and short-term survival in patients with Candida bloodstream infection.

Authors:  S Takakura; N Fujihara; T Saito; T Kudo; Y Iinuma; S Ichiyama
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-04-27       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.